culture
Medication for MS Symptoms: What to Know
A practical overview of medication options for managing MS symptoms, including disease-modifying therapies, symptom-specific drugs, and what patients should discuss with their c...
Every article on Detroit Bureau about Disease Modifying Therapy — 9 stories covering it, newest first.
news
Cladribine (Mavenclad): What It Is, How It Works, and What to Expect
Cladribine (Mavenclad) is an oral treatment for relapsing forms of multiple sclerosis. This article covers its mechanism, dosing, side effects, eligibility, and practical consid...
community
New Treatment for Multiple Sclerosis: What the Latest Options Mean for Patients
A rundown of new treatment for multiple sclerosis options, including disease-modifying therapies, oral medications, and emerging approaches that are reshaping care for MS patients.
community
Cures for Multiple Sclerosis: What the Evidence Shows
No cure exists for multiple sclerosis yet, but disease-modifying therapies, symptom management, and emerging research are changing long-term outcomes.
culture
Treating Multiple Sclerosis: Current Approaches and What Patients Should Know
An overview of treating multiple sclerosis, including disease-modifying therapies, symptom management, lifestyle strategies, and how treatment plans are tailored to different MS...
culture
New MS Treatments: What's Changing in Multiple Sclerosis Care
Overview of newly approved and emerging MS treatments, how they work, who qualifies, and what to ask your neurologist.
news
New Treatment MS: What's Changing in Multiple Sclerosis Therapy
Overview of new treatment MS options, including disease-modifying therapies, oral medications, and emerging approaches that are reshaping multiple sclerosis management.
sports
New MS Drugs: What the Latest Treatments Mean for Patients
An overview of newly approved and emerging MS drugs, how they work, who they help, and what patients should know about side effects, access, and treatment decisions.
community
Prognosis of Spinal Muscular Atrophy: What Families and Clinicians Need to Know
Understanding the prognosis of spinal muscular atrophy by type, the impact of early intervention, disease-modifying therapies, and key factors that shape long-term outcomes.
Topic